Human immunodeficiency virus type 1 stimulates the expression and production of secretory leukocyte protease inhibitor (SLPI) in oral epithelial cells: a role for SLPI in innate mucosal immunity
about
The phospholipid scramblases 1 and 4 are cellular receptors for the secretory leukocyte protease inhibitor and interact with CD4 at the plasma membraneWFDC1/ps20 is a novel innate immunomodulatory signature protein of human immunodeficiency virus (HIV)-permissive CD4+ CD45RO+ memory T cells that promotes infection by upregulating CD54 integrin expression and is elevated in HIV type 1 infectionSalivary defense proteins: their network and role in innate and acquired oral immunityThe mouth: a gateway or a trap for HIV?Innate immunity against HIV: a priority target for HIV prevention researchHIV is inactivated after transepithelial migration via adult oral epithelial cells but not fetal epithelial cells.Female genital tract secretions and semen impact the development of microbicides for the prevention of HIV and other sexually transmitted infections.Secretory leukocyte protease inhibitor plays an important role in the regulation of allergic asthma in mice.Systemic and mucosal differences in HIV burden, immune, and therapeutic responsesSecretory leukocyte protease inhibitor binds to Neisseria gonorrhoeae outer membrane opacity protein and is bactericidalRespiratory protease/antiprotease balance determines susceptibility to viral infection and can be modified by nutritional antioxidantsShort communication: Increased expression of secretory leukocyte protease inhibitor in oral mucosa of Colombian HIV type 1-exposed seronegative individuals.Innate Antibacterial Activity in Female Genital Tract Secretions Is Associated with Increased Risk of HIV Acquisition.Oral innate immunity in HIV infection in HAART eraHuman beta-defensins 2 and -3 cointernalize with human immunodeficiency virus via heparan sulfate proteoglycans and reduce infectivity of intracellular virions in tonsil epithelial cellsHerpes simplex virus downregulates secretory leukocyte protease inhibitor: a novel immune evasion mechanismEstimation and comparison of salivary secretory leukocyte protease inhibitor in human immunodeficiency virus patients and healthy individuals.HIV Infection and Compromised Mucosal Immunity: Oral Manifestations and Systemic Inflammation.Innate antiviral immunity of periodontal tissue.Oral fungi in HIV: challenges in antifungal therapies.Innate immunity in HIV-1 infection: epithelial and non-specific host factors of mucosal immunity- a workshop report.Distribution and factors associated with salivary secretory leukocyte protease inhibitor concentrations.Shosaikoto increases calprotectin expression in human oral epithelial cells.Effect of Hangeshashinto on calprotectin expression in human oral epithelial cells.Differential effects of periopathogens on host protease inhibitors SLPI, elafin, SCCA1, and SCCA2.MxA expression induced by α-defensin in healthy human periodontal tissue.Arginine-specific gingipains from Porphyromonas gingivalis deprive protective functions of secretory leucocyte protease inhibitor in periodontal tissue.
P2860
Q21143809-2651B469-FFD1-43B8-9708-1913DF31B9D0Q24657262-50EE2BB4-A8D8-4615-9791-66425027419CQ30467494-98AFAEC2-EDD9-4AB5-8B4B-E65DEB013E44Q33874252-FF2CB2BD-08C0-4B74-8197-3F24508D02FEQ34243462-D127E08D-A707-4DE8-820C-589BF8977F0FQ34554611-33DE741F-5E65-48B3-B3B4-0659B1D33992Q34680240-5ED83392-63C9-402E-9CC9-0E734265BD92Q35014657-E58B234C-C1AA-4C79-820C-51D783612F14Q35190200-AA949091-9282-474A-BADE-020965A31BBEQ36092095-07BA02AA-3660-4E26-A514-00F0973B164FQ36104532-2D7E9A52-3DCF-4C3D-BC5C-366C55064505Q36177527-7A390017-7238-4446-A0C4-77EE93946D54Q36294689-EAFB265C-F6C6-4240-B52D-536E09C5232BQ36352384-9802E023-A3FE-49FC-8A02-5110AE5ADB6BQ36373244-B772C784-21C1-41FF-9AB1-5F506BCFFFF1Q36898823-2C5A5AB2-D9B2-4290-9F75-606E90879F59Q37596710-C8A7395C-5009-4F06-BA9F-4042BD1DA7F3Q37683137-754647D3-FD48-45C2-8501-9F43778F9840Q37866356-DB853E44-FBF5-4F6F-9C56-19B3B7ED5954Q38816198-A8E9B252-6A7E-4AE5-9E16-3A84055ADBEAQ38816202-2566FA4C-E947-4101-856D-B946A933C4ADQ39547383-40500BFD-D09A-4649-8EEB-F3CA90FB8638Q39825416-27DADDED-89E6-4F05-A2A3-85597580B5B1Q41505187-16FC24DF-1FE5-4E39-A0BC-68558AAC50A9Q42723859-B1B1115A-261E-4CBC-A0A4-5B04F9B5F952Q45722167-A821168D-FF44-434A-BCEA-8AED8314EAA2Q54587595-05CDF63E-B3F7-4119-A4FA-646F73A6AE9E
P2860
Human immunodeficiency virus type 1 stimulates the expression and production of secretory leukocyte protease inhibitor (SLPI) in oral epithelial cells: a role for SLPI in innate mucosal immunity
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Human immunodeficiency virus t ...... LPI in innate mucosal immunity
@ast
Human immunodeficiency virus t ...... LPI in innate mucosal immunity
@en
type
label
Human immunodeficiency virus t ...... LPI in innate mucosal immunity
@ast
Human immunodeficiency virus t ...... LPI in innate mucosal immunity
@en
prefLabel
Human immunodeficiency virus t ...... LPI in innate mucosal immunity
@ast
Human immunodeficiency virus t ...... LPI in innate mucosal immunity
@en
P2093
P2860
P1433
P1476
Human immunodeficiency virus t ...... LPI in innate mucosal immunity
@en
P2093
P2860
P304
P356
10.1128/JVI.79.10.6432-6440.2005
P577
2005-05-01T00:00:00Z